Registered number
11740605
Sander Pharma Limited
Filleted Accounts
31 August 2024
Sander Pharma Limited
Registered number: 11740605
Balance Sheet
as at 31 August 2024
Notes 2024 2023
£ £
Fixed assets
Intangible assets 3 285,000 304,000
Tangible assets 4 10,833 13,158
295,833 317,158
Current assets
Stocks 28,533 55,776
Debtors 5 87,416 89,007
Cash at bank and in hand 89,969 68,127
205,918 212,910
Creditors: amounts falling due within one year 6 (222,264) (253,014)
Net current liabilities (16,346) (40,104)
Total assets less current liabilities 279,487 277,054
Creditors: amounts falling due after more than one year 7 (222,393) (244,289)
Net assets 57,094 32,765
Capital and reserves
Called up share capital 100 100
Profit and loss account 56,994 32,665
Shareholders' funds 57,094 32,765
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Mr Viralbhai Kantibhai Patel
Director
Approved by the board on 29 August 2025
Sander Pharma Limited
Notes to the Accounts
for the year ended 31 August 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Intangible fixed assets
Intangible fixed assets are measured at cost less accumulative amortisation and any accumulative impairment losses.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Plant and machinery over 5 years
Fixtures, fittings, tools and equipment over 5 years
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 3 3
3 Intangible fixed assets £
Goodwill:
Cost
At 1 September 2023 380,000
At 31 August 2024 380,000
Amortisation
At 1 September 2023 76,000
Provided during the year 19,000
At 31 August 2024 95,000
Net book value
At 31 August 2024 285,000
At 31 August 2023 304,000
Goodwill is being written off in equal annual instalments over its estimated economic life of 20 years.
4 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 September 2023 33,639
Additions 383
At 31 August 2024 34,022
Depreciation
At 1 September 2023 20,481
Charge for the year 2,708
At 31 August 2024 23,189
Net book value
At 31 August 2024 10,833
At 31 August 2023 13,158
5 Debtors 2024 2023
£ £
Trade debtors 75,993 84,139
Other debtors 11,423 4,868
87,416 89,007
6 Creditors: amounts falling due within one year 2024 2023
£ £
Bank loans and overdrafts 5,619 20,598
Trade creditors 4,361 7,354
Taxation and social security costs 37,563 32,138
Other creditors 174,721 192,924
222,264 253,014
7 Creditors: amounts falling due after one year 2024 2023
£ £
Bank loans 222,393 244,289
8 Other information
Sander Pharma Limited is a private company limited by shares and incorporated in England. Its registered office is:
36 Camplin Road
Harrow
England
HA3 9LT
Sander Pharma Limited 11740605 false 2023-09-01 2024-08-31 2024-08-31 VT Final Accounts July 2024 Mr Viralbhai Kantibhai Patel No description of principal activity 11740605 2022-09-01 2023-08-31 11740605 core:WithinOneYear 2023-08-31 11740605 core:AfterOneYear 2023-08-31 11740605 core:ShareCapital 2023-08-31 11740605 core:RetainedEarningsAccumulatedLosses 2023-08-31 11740605 2023-09-01 2024-08-31 11740605 bus:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 11740605 bus:AuditExemptWithAccountantsReport 2023-09-01 2024-08-31 11740605 bus:Director40 2023-09-01 2024-08-31 11740605 1 2023-09-01 2024-08-31 11740605 2 2023-09-01 2024-08-31 11740605 core:Goodwill 2023-09-01 2024-08-31 11740605 core:PlantMachinery 2023-09-01 2024-08-31 11740605 countries:England 2023-09-01 2024-08-31 11740605 bus:FRS102 2023-09-01 2024-08-31 11740605 bus:FilletedAccounts 2023-09-01 2024-08-31 11740605 2024-08-31 11740605 core:WithinOneYear 2024-08-31 11740605 core:AfterOneYear 2024-08-31 11740605 core:ShareCapital 2024-08-31 11740605 core:RetainedEarningsAccumulatedLosses 2024-08-31 11740605 core:Goodwill 2024-08-31 11740605 core:PlantMachinery 2024-08-31 11740605 2023-08-31 11740605 core:Goodwill 2023-08-31 11740605 core:PlantMachinery 2023-08-31 iso4217:GBP xbrli:pure